Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Doctor’s book tells story of researching his own rare disease.
EURORDIS-Rare Diseases Europe bestows posthumous honor on the actress and humanitarian; Hepburn’s son is an advocate for rare…
Born with a rare, genetic disease, an HAE patient shared her story with CSL Behring staff in Kankakee, Illinois
Could “koselig” help you cozy up to the chilliest time of the year? Alpha 1 athlete Karen Skålvoll explains.
CSL’s CEO reflects on the importance of recognizing Rare Disease Day.
Employees in Switzerland share frosty photos from historic Bern, a dream destination for cold-weather travelers.
Photographer Richard Lovrich has created an atmospheric photo series during his daily dog walks, which the rare disease patie…
Chief Human Resources Officer Elizabeth Walker offers advice for driving your professional success.
Behind the trendy term, there’s a commonsense concept that can make a difference for patients living with chronic illness.
It’s not just what we do - it’s how we do it.
Despite setbacks, Jonathan Maidment didn’t give up - and raised $60,000 for the rare disease.
CSL Behring named Penn State University’s Corporate Partner of the Year.
Popular search terms:
Americas
Asia Pacific
Europe
